# Latanoprost Preserved Versus Unpreserved: Effect on Tear Film Thickness as Measured With OCT

> **NCT02585375** · PHASE4 · UNKNOWN · sponsor: **Medical University of Vienna** · enrollment: 70 (estimated)

## Conditions studied

- Glaucoma
- Ocular Hypertension

## Interventions

- **DRUG:** Preservative-free latanoprost 50µg/ml
- **DRUG:** Preserved latanoprost 0.005%

## Key facts

- **NCT ID:** NCT02585375
- **Lead sponsor:** Medical University of Vienna
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-09-17
- **Primary completion:** 2023-09
- **Final completion:** 2023-09-02
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2022-04-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02585375

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02585375, "Latanoprost Preserved Versus Unpreserved: Effect on Tear Film Thickness as Measured With OCT". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02585375. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*